Pediatric kidney transplantation literature review 2006

Pediatric Transplantation

Volumn 11, Issue 4, 2007, Pages 354-365

  Dharnidharka, Vikas R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Division of Pediatric Nephrology   (United States)

Author keywords

Children; Kidney transplantation; Pediatrics

Indexed keywords

CHILD HEALTH; KIDNEY TRANSPLANTATION; MEDICAL LITERATURE; PEER REVIEW; PUBLICATION; REVIEW;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CHILD; CLINICAL TRIALS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-18; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES; PROGNOSIS; PROTO-ONCOGENE PROTEINS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 34247586282     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00724.x     Document Type: Review

References (11)

1. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001 : 10 : 726 31.
2. Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000 : 58 : 1311 1317.
3. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005 : 9466 : 1231 1238.
4. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004 : 43 : 405 414.
5. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006 : 6 : 1639 1645.
6. Josephson MA. Rabbit antithymocyte globulin or basiliximab for induction therapy? N Engl J Med 2006 : 19 : 2033 2035.
7. Dharnidharka VR, Stevens G. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant 2005 : 9 : 622 626.
8. Filler G, Lampe D, Von Bredow MA, et al. Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics. Pediatr Nephrol 1998 : 12 : 6 9.
9. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003 : 9 : 1331 1339.
10. Schachter AD, Meyers KE, Spaneas LD, et al. Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant 2004 : 8 : 171 177.
11. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 2004 : 4 : 384 389.